Candel Therapeutics Inc.
CADL | NASDAQ
$11.56
+$0.35 (+3.12%)
Sep 22, 2026, 10:52 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 31K | 31K | 31K | 31K | 31K | 31K | 31K | 31K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 31K | 31K | 31K | 31K | 31K | 31K | 31K | 31K |
Operating Income | -26.75M | -16.28M | -15.75M | -13.21M | -11.18M | -8.13M | -8.14M | -8.76M | -8.57M | -7.9M | -10.32M | -8.86M | -9.58M | -9.63M | -8.1M | -8.88M | -8.75M | -8.99M | -7.74M | -8.03M | -5.3M | -4.66M |
Interest Income | 1.67M | 1.32M | 1.1M | 953K | 926K | 934K | 290K | 236K | 240K | 320K | 415K | 502K | 453K | 711K | n/a | 343K | 70K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -38.91M | -8.86M | -29.5M | -11.27M | -4.8M | 7.38M | -14.07M | -10.65M | -22.24M | -8.22M | -11.1M | -8.44M | -9.61M | -8.8M | -5.08M | -8.69M | -4.15M | -874K | 1.6M | -16.16M | -17.08M | -4.48M |
Net Income | -38.91M | -8.86M | -29.5M | -11.27M | -4.8M | 7.38M | -14.07M | -10.65M | -22.24M | -8.22M | -11.1M | -8.44M | -9.61M | -8.8M | -5.08M | -8.69M | -4.15M | -874K | 1.6M | -16.16M | -17.08M | -4.48M |
Selling & General & Admin | 6.95M | 6.44M | 4.72M | 4.75M | 4.19M | 4.11M | 3.32M | 3.34M | 3.59M | 3.8M | 3.06M | 3.02M | 3.65M | 4.16M | 3.16M | 3.54M | 3.76M | 3.6M | 3.92M | 2.8M | 2.04M | 1.94M |
Research & Development | 19.8M | 9.84M | 11.03M | 8.46M | 6.99M | 4.02M | 4.82M | 5.42M | 4.98M | 4.1M | 7.26M | 5.85M | 5.93M | 5.47M | 4.97M | 5.38M | 5.02M | 5.42M | 3.85M | 5.27M | 3.29M | 2.75M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -48K | n/a | n/a | n/a | -149K | n/a | -605K | -191K |
Operating Expenses | 26.75M | 16.28M | 15.75M | 13.21M | 11.18M | 8.13M | 8.14M | 8.76M | 8.57M | 7.9M | 10.32M | 8.86M | 9.58M | 9.63M | 8.08M | 8.91M | 8.78M | 9.02M | 7.62M | 8.06M | 4.73M | 4.5M |
Interest Expense | 1.58M | 1.56M | 1.42M | 161K | 236K | 306K | 390K | 487K | 567K | 646K | 673K | 669K | 644K | 609K | n/a | 519K | 435K | 175K | 11K | n/a | 15K | 12K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 26.75M | 16.28M | 15.75M | 13.21M | 11.18M | 8.13M | 8.14M | 8.76M | 8.57M | 7.9M | 10.32M | 8.86M | 9.58M | 9.63M | 8.08M | 8.91M | 8.78M | 9.02M | 7.62M | 8.06M | 4.73M | 4.5M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 74.13M | 62.36M | 54.9M | 54.89M | 51.49M | 31.68M | 35.56M | 32.01M | 29.88M | 29.2M | 28.98M | 28.92M | 28.92M | 28.92M | 28.9M | 28.89M | 28.81M | 28.69M | 23.33M | 23.33M | 24.8M | 18.71M |
Shares Outstanding (Diluted) | 74.13M | 62.36M | 54.9M | 54.89M | 51.49M | 31.68M | 35.56M | 32.01M | 29.88M | 29.2M | 28.98M | 28.92M | 28.92M | 28.92M | 28.9M | 28.89M | 28.81M | 28.69M | 23.33M | 23.33M | 24.8M | 18.71M |
EPS (Basic) | -0.52 | -0.14 | -0.54 | -0.21 | -0.09 | 0.23 | -0.40 | -0.33 | -0.74 | -0.28 | -0.38 | -0.29 | -0.33 | -0.30 | -0.18 | -0.29 | -0.14 | -0.03 | 0.07 | -0.69 | -0.69 | -0.24 |
EPS (Diluted) | -0.52 | -0.14 | -0.54 | -0.21 | -0.09 | 0.23 | -0.40 | -0.33 | -0.74 | -0.28 | -0.38 | -0.29 | -0.33 | -0.30 | -0.18 | -0.29 | -0.14 | -0.03 | 0.07 | -0.69 | -0.69 | -0.24 |
EBITDA | -14.49M | -7.15M | -27.92M | -10.91M | -4.32M | 7.93M | -13.44M | -9.91M | -21.42M | -7.32M | -10.17M | -7.52M | -8.73M | -7.96M | -7.83M | -7.96M | -3.53M | -8.82M | 1.79M | -16.16M | -4.69M | -4.44M |
EBIT | -14.49M | -7.3M | -28.08M | -11.11M | -4.56M | 7.69M | -13.68M | -10.16M | -21.67M | -7.58M | -10.42M | -7.77M | -8.97M | -8.19M | -8.05M | -8.17M | -3.71M | -8.99M | 1.61M | -16.16M | -4.7M | -4.47M |
Depreciation & Amortization | n/a | 149K | 163K | 195K | 242K | 245K | 245K | 245K | 249K | 251K | 249K | 245K | 236K | 230K | 221K | 205K | 187K | 165K | 178K | n/a | 7K | 26K |
Add to Watchlist
Select watchlists to add or remove CADL